Literature DB >> 3541897

Insulin binding to cultured adult hepatocytes. Effects of bacitracin and chloroquine on the nature of cell-associated radioactivity.

W E Fleig, G Hoss, G Nöther-Fleig, H Ditschuneit.   

Abstract

Sephadex (G-50 fine grade)-gel chromatography and trichloroacetic acid (TCA) precipitation were used to investigate the effects of chloroquine and bacitracin on the nature of cell-associated radioactivity in studies on the binding and degradation of 125I-insulin in cultured rat hepatocytes. Sephadex peak I, eluted with the void volume, increased with hepatocyte incubation time and comprised 6% of total cell-bound radioactivity at 120 min. However, all radioactivity in this peak was due to unspecific binding. Peak II, corresponding to intact insulin, represented 95% of specifically cell-associated label at 5 min and decreased to 77% at 120 min. Peak III, containing the final low-Mr degradation products, increased with incubation time (22% of specifically bound label at 120 min). The TCA-precipitable and TCA-soluble fractions of hepatocytes extracted with 0.1% SDS were within 4-7% of the proportions of radioactivity in peaks II and III respectively. Scatchard plots based on insulin-binding data from Sephadex chromatography or TCA precipitation were identical. Dissociation studies revealed that at least 75% of the intact insulin associated with the hepatocytes was bound to receptors at the cell surface. Bacitracin increased the proportion of cell-associated intact hormone and decreased that of ligand degraded when analysed by either Sephadex chromatography or TCA precipitation. The proportion of surface-bound to internalized intact hormone remained unaltered, indicating that bacitracin acted predominantly at the cell surface. In the presence of chloroquine, which dramatically increased the contribution of peak I to specific binding, 'intact' insulin was substantially overestimated when determined as the TCA-precipitable fraction. In addition, all peak I material and 50% of cell-associated label in peak II was trapped intracellularly, thereby pointing to the lysosomal or prelysosomal site of action of this drug.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3541897      PMCID: PMC1146952          DOI: 10.1042/bj2370099

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

2.  Insulin processing by the liver.

Authors:  J F Caro; G Muller; J A Glennon
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

3.  Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells.

Authors:  H T Haigler; F R Maxfield; M C Willingham; I Pastan
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

4.  Functional relationships between insulin binding, action, and degradation. A reassessment.

Authors:  J F Caro; J M Amatruda
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

5.  Bacitracin: an inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenase.

Authors:  R A Roth
Journal:  Biochem Biophys Res Commun       Date:  1981-01-30       Impact factor: 3.575

6.  Peptide intermediates in the cellular metabolism of insulin.

Authors:  R K Assoian; H S Tager
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

7.  Receptor-mediated insulin degradation and insulin-stimulated glycogenesis in cultured foetal hepatocytes.

Authors:  C Plas; B Desbuquois
Journal:  Biochem J       Date:  1982-02-15       Impact factor: 3.857

8.  Evidence for modulation of insulin action and degradation independently of insulin binding.

Authors:  J F Caro; J M Amatruda
Journal:  Am J Physiol       Date:  1981-03

9.  Lysosomal degradation of receptor-bound 125I-labeled insulin by rat adipocytes: its characterization and dissociation from the short-term biologic effects of insulin.

Authors:  G T Hammons; L Jarett
Journal:  Diabetes       Date:  1980-06       Impact factor: 9.461

10.  High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study.

Authors:  M N Berry; D S Friend
Journal:  J Cell Biol       Date:  1969-12       Impact factor: 10.539

View more
  3 in total

1.  Uncoupling between the insulin-receptor cycle and the cellular degradation of the hormone in cultured foetal hepatocytes. Effect of drugs and temperature that inhibit insulin degradation.

Authors:  P Soubigou; M Ali; C Plas
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

2.  Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme.

Authors:  J R McDermott; A M Gibson
Journal:  Neurochem Res       Date:  1997-01       Impact factor: 3.996

Review 3.  Targeting Insulin-Degrading Enzyme in Insulin Clearance.

Authors:  Malcolm A Leissring; Carlos M González-Casimiro; Beatriz Merino; Caitlin N Suire; Germán Perdomo
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.